Breast cancer patients’ stratification in molecular subtype was performed by a prediction analysis of microarray 50 (PAM50) [33], a 50-gene signature that classifies breast cancer into five subgroups: basal-like, HER2-enriched, luminal A, luminal B, and normal-like. The gene discussed is ERBB2; the disease is breast carcinoma.